10.050
+0,60%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1041.9% | +443.6% | 3 / 3 | -19.4% | +21.05 pp | +15.37 pp | +4.2% | 0.05 | 20.83 | 106 | −19,4% | 16,9 | +2.481,4% | 20.83 | 33.40 | −37,6% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 10.050 (close price on 2026-10-19)EPS (TTM): 482,5
Financial charts
1.Revenue & growth
VND bn106Q2/26
1.Revenue & growth
VND bn106Q2/26
2.Profit & growth
VND bn8,58Q2/26
3.Profit mix (Penman)
VND bn59,2Q2/26
4.Margins & cost structure
%8.0%Q2/26
5.Returns & cash cycle
% · days9.6%Q2/26
6.Earnings quality & cash
VND bn96,5Q2/26
7.Asset structure
VND bn753Q2/26
8.Funding & debt health
VND bn · times753Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %20,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %168Q2/26
Adjusted EPS growth, latest quarter
11,4× higher
Average adjusted EPS growth, 3 quarters
547%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26